Oxaliplatin
Oxaliplatin is a third generation platinum anticancer agent used in combination with 5-Fluorouracil and Folinic acid (=FOLFOX regimen) for the treatment of metastatic colorectal cancer.
Oxaliplatin is on the World Health Organization model list of essential medicines.
Therapeutic group
Antineoplastic agents, platinum compounds
ATC code: L01XA03
Oxaliplatin is on the World Health Organization model list of essential medicines.
Therapeutic group
Antineoplastic agents, platinum compounds
ATC code: L01XA03
Oxaliplatin
Key dosage forms
- Injectable (5 mg/mL)
Features
- Wide coverage, two processes covering three different standards: USP and EP/JP
- Market leader, producing more than 15% of the global market
- Reliable and steady supply
Some brand names
- ELOXATIN® (SANOFI)
- OXITAN® (FRESENIUS)